Related Experiment Video
Updated: Feb 14, 2026

The Other End of the Leash: An Experimental Test to Analyze How Owners Interact with Their Pet Dogs
Published on: October 13, 2017
Immunotherapy for Dogs: Running Behind Humans
1NantKwest, Inc., Culver City, CA, United States.
Abstract:
A number of excellent reviews on the potential of canine cancer immunotherapy are available, but many extrapolate from observations in humans when in fact only very few immunotherapies have been developed for canines that have shown efficacy in well-designed studies. Pharmaceutical and biotech companies are aware that the market for more expensive immunotherapies in canines is limited resulting in limited funding for clinical trials. However, dogs and other pets deserve access to this new form of cancer therapy. The purpose of this brief review is to summarize the current status of available immunotherapies for dogs and their near-term prospects, provided we can effectively translate discoveries and progress in humans to canines.
Insights
Canine cancer immunotherapy shows promise, but few effective treatments exist for dogs. Translating human discoveries could improve canine cancer therapy options.
Area of Science:
- Veterinary Oncology
- Immunotherapy Research
- Comparative Medicine
Background:
- Existing reviews on canine cancer immunotherapy often rely on human data, lacking robust canine-specific evidence.
- Limited clinical trials and funding hinder the development of effective immunotherapies for dogs due to market size concerns.
- Despite challenges, there is a recognized need to advance novel cancer treatments for companion animals.
Purpose of the Study:
- To review the current landscape of immunotherapies available for canine cancer.
- To assess the near-term prospects for canine cancer immunotherapy.
- To explore the potential for translating human immunotherapy advancements to canine applications.
Main Methods:
- Literature review of published studies on canine cancer immunotherapy.
- Analysis of clinical trial data and regulatory approvals for veterinary cancer treatments.
- Comparative assessment of human and canine immunotherapy research.
Main Results:
- Few immunotherapies have demonstrated efficacy in well-designed canine studies.
- Market limitations and funding challenges restrict the development of new canine immunotherapies.
- Progress in human immunotherapy offers potential avenues for canine treatment translation.
Conclusions:
- Canine cancer immunotherapy is an emerging field with significant unmet needs.
- Effective translation of human immunotherapy research is crucial for advancing canine cancer care.
- Further investment and research are required to realize the potential of immunotherapy for dogs.
Related Concept Videos
Tumor Immunotherapy
Wald-Wolfowitz Runs Test II
For binary data, runs are identified using symbols such as + and −, or equivalently, 1s and 0s. In...
Wald-Wolfowitz Runs Test I
The test works...
Biodiversity and Human Values
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Dimensional Analysis
Conversion Factors and Dimensional Analysis
The unit...

